These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9889140)

  • 1. Recent work on Alzheimer's disease transgenics.
    Duff K
    Curr Opin Biotechnol; 1998 Dec; 9(6):561-4. PubMed ID: 9889140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
    Obulesu M; Somashekhar R; Venu R
    Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward valid transgenic mouse models for Alzheimer's disease.
    Guénette SY; Tanzi RE
    Neurobiol Aging; 1999; 20(2):201-11. PubMed ID: 10537029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein.
    Bates KA; Fonte J; Robertson TA; Martins RN; Harvey AR
    Neuroscience; 2002; 113(4):785-96. PubMed ID: 12182886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
    Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
    Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels.
    Köhler C; Ebert U; Baumann K; Schröder H
    Neurobiol Dis; 2005 Nov; 20(2):528-40. PubMed ID: 15921918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
    Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
    Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and Alzheimer's.
    van Bockxmeer FM
    Nature; 1995 May; 375(6529):285. PubMed ID: 7753191
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
    Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
    Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of transgenic animal models for Alzheimer's disease].
    Watanabe N; Tabira T
    No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475
    [No Abstract]   [Full Text] [Related]  

  • 15. Genes implicated in the pathogenesis of Alzheimer's disease.
    Das HK; Lal H
    Front Biosci; 1997 Jun; 2():d253-9. PubMed ID: 9206974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.
    Kuo YM; Crawford F; Mullan M; Kokjohn TA; Emmerling MR; Weller RO; Roher AE
    Mol Med; 2000 May; 6(5):430-9. PubMed ID: 10952022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
    Bales KR; Verina T; Dodel RC; Du Y; Altstiel L; Bender M; Hyslop P; Johnstone EM; Little SP; Cummins DJ; Piccardo P; Ghetti B; Paul SM
    Nat Genet; 1997 Nov; 17(3):263-4. PubMed ID: 9354781
    [No Abstract]   [Full Text] [Related]  

  • 20. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.